Nature Reviews Gastroenterology & Hepatology

(ISSN: 1759-5045)

Table of Contents

2012 - 9 (12)

  • IBD: Elafin--a potential IBD therapy. 
  • Gallbladder: Loss of interstitial Cajal-like cells in the gallbladder might contribute to gallstone formation. 
  • Colorectal cancer: CRC--all about microbial products and barrier function? 
  • IBD: Ustekinumab shows promise in the treatment of refractory Crohn's disease. 
  • Viral hepatitis: a rare dendritic cell population produces IFN-λ in HCV infection. 
  • Pancreatic cancer: New genetic insights into pancreatic cancer. 
  • Imaging: a novel technique for imaging enteric ganglia. 
  • IBD: the IBD genome--new study findings contribute to an ever-growing gene catalogue. 
  • Diagnosis: Novel prognostic biomarkers in hepatocellular carcinoma. 
  • Management of psoriatic lesions associated with anti-TNF therapy in patients with IBD. 
  • Microbiota: Gut microbiota produce alcohol in patients with NASH. 
  • Physical activity: an essential component of lifestyle modification in NAFLD. 
  • Infection: Activation of Hedgehog pathway promotes fibrogenesis and vascular remodelling in human schistosomiasis. 
  • Colorectal cancer: Comparison of colorectal cancer screening strategies. 
  • Ulcerative colitis: UCCIS--a reproducible tool to assess mucosal healing. 
  • Treatment of colorectal cancer in older patients. 
  • Ghrelin, the proglucagon-derived peptides and peptide YY in nutrient homeostasis. 
  • Therapeutic concepts in adult and paediatric eosinophilic oesophagitis. 
  • Hepatocellular carcinoma--resection or transplant? 
  • Application of whole-organ tissue engineering in hepatology. 
 
 

Journal Information

Mission Statement: Nature Reviews Gastroenterology & Hepatology commissions leaders in the field to write clinical content of the highest quality, authority and accessibility.